Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
John Peters Evans, MD
Family Practice · CARROLL, IA · NPI 1700874054
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 590 | 94 |
| Losartan Potassium | Losartan Potassium | 393 | 81 |
| Amlodipine Besylate | Amlodipine Besylate | 377 | 91 |
| Metoprolol Succinate | Metoprolol Succinate | 338 | 67 |
| Atorvastatin Calcium | Atorvastatin Calcium | 290 | 61 |
| Omeprazole | Omeprazole | 287 | 43 |
| Lisinopril | Lisinopril | 269 | 71 |
| Famotidine | Famotidine | 252 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 236 | 51 |
| Sertraline Hcl | Sertraline Hcl | 216 | 36 |
| Furosemide | Furosemide | 181 | 29 |
| Pantoprazole Sodium | Pantoprazole Sodium | 180 | 35 |
| Metformin Hcl | Metformin Hcl | 178 | 31 |
| Gabapentin | Gabapentin | 175 | 33 |
| Eliquis | Apixaban | 170 | 32 |
| Lovastatin | Lovastatin | 157 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 151 | 37 |
| Simvastatin | Simvastatin | 143 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 142 | 28 |
| Potassium Chloride | Potassium Chloride | 131 | 28 |
| Risperidone | Risperidone | 105 | suppressed |
| Finasteride | Finasteride | 102 | 13 |
| Prednisone | Prednisone | 97 | 24 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 96 | 21 |
| Allopurinol | Allopurinol | 94 | 24 |
| Pregabalin | Pregabalin | 86 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 85 | 12 |
| Donepezil Hcl | Donepezil Hcl | 82 | suppressed |
| Glipizide | Glipizide | 81 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 79 | 12 |
| Tramadol Hcl | Tramadol Hcl | 70 | 24 |
| Klor-Con M20 | Potassium Chloride | 68 | 11 |
| Lorazepam | Lorazepam | 68 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 67 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 65 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 64 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 60 | 13 |
| Carvedilol | Carvedilol | 59 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 56 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 56 | 11 |
| Alendronate Sodium | Alendronate Sodium | 54 | 15 |
| Montelukast Sodium | Montelukast Sodium | 50 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 45 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 44 | 19 |
| Metformin Hcl Er | Metformin Hcl | 44 | 12 |
| Valsartan | Valsartan | 43 | 13 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 42 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 41 | suppressed |
| Meloxicam | Meloxicam | 41 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 38 | 12 |
| Ozempic | Semaglutide | 37 | suppressed |
| Olanzapine | Olanzapine | 36 | suppressed |
| Januvia | Sitagliptin Phosphate | 34 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 32 | 12 |
| Mirtazapine | Mirtazapine | 32 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Enulose | Lactulose | 31 | suppressed |
| Synthroid | Levothyroxine Sodium | 31 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | suppressed |
| Motegrity | Prucalopride Succinate | 29 | suppressed |
| Spironolactone | Spironolactone | 29 | 12 |
| Baclofen | Baclofen | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 21 |
| Torsemide | Torsemide | 28 | suppressed |
| Clonazepam | Clonazepam | 27 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 27 | suppressed |
| Novolog Flexpen | Insulin Aspart | 27 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 27 | suppressed |
| Carbamazepine | Carbamazepine | 26 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 26 | suppressed |
| Phenytoin | Phenytoin | 26 | suppressed |
| Bupropion Xl | Bupropion Hcl | 25 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 24 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 18 |
| Memantine Hcl | Memantine Hcl | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 22 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 22 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 21 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Atenolol | Atenolol | 20 | suppressed |
| Fluconazole | Fluconazole | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 20 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 19 | suppressed |
| Celecoxib | Celecoxib | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Constulose | Lactulose | 18 | suppressed |
| Sodium Chloride | Sodium Chloride Irrig Solution | 18 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 17 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Jardiance | Empagliflozin | 17 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 16 |
| Xarelto | Rivaroxaban | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Norgestimate-Ethinyl Estradiol | Norgestimate-Ethinyl Estradiol | 15 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 13 | 13 |
| Aliskiren | Aliskiren Hemifumarate | 13 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 13 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 13 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 13 | suppressed |
| Ultra-Fine Original Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Atacand | Candesartan Cilexetil | 12 | suppressed |
| Azithromycin | Azithromycin | 12 | 11 |
| Balsalazide Disodium | Balsalazide Disodium | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 12 | suppressed |
| Ezetimibe | Ezetimibe | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Konvomep | Omeprazole/Sodium Bicarbonate | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Ibuprofen | Ibuprofen | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error